Researchers at the WPI-Nano Life Science Institute, Kanazawa University, have made pioneering advancements in the field of cancer research, as reported in ACS Applied Nano Materials. They have developed a novel method called Nanoendoscopy-AFM (NE-AFM) to measure the stiffness or softness of cell nuclei in living cancer cells. This technique provides crucial insights into the mechanical properties of cancer cells, which are important indicators of disease progression and potential treatment outcomes.

Understanding Nuclear Elasticity

The elasticity of cell nuclei can indicate various physiological conditions within the cell. Using NE-AFM, researchers can insert a nanoneedle probe directly into living cells. This approach allows them to measure the nuclear elasticity without causing significant damage to the cells. Traditional methods of studying nuclear mechanics, including using atomic force microscopy (AFM) probes, have limitations that prevent accurate assessments of intact nuclear states.

Key Findings

The team found that human lung cancer cells (PC9) exhibited increased nuclear elasticity under serum-free conditions. This change was associated with heightened trimethylation of histone H4 at lysine 20 (H4K20me3), a marker of chromatin compaction. Conversely, when treated with transforming growth factor beta (TGF-β), which induces epithelial-mesenchymal transition (EMT), the researchers noted a softening of the nuclei and a decrease in H4K20me3 levels.

The Methodology of NE-AFM

NE-AFM integrates advanced nanotechnology with traditional microscopy to enable detailed monitoring of nuclear mechanics. The researchers used nanoneedle probes, approximately 160 nm in diameter, which can be inserted into living cells numerous times to gather extensive data. Below is an overview of the method and its impact:

Aspect Description Advantages
Technique Nanoendoscopy-AFM Minimally invasive, allows repeated measurements
Probes Nanoneedle, ~160 nm in diameter Enables precise indentation of nuclear structures
Findings Nuclear elasticity changes correlate with chromatin states Potential biomarkers for cancer diagnosis and treatment

Implications for Cancer Treatment

The discovery that nuclear elasticity is linked to chromatin compaction opens new avenues for understanding cancer biology. As nuclear mechanics reflect underlying cellular mechanisms, they may serve as viable biomarkers for:

  • Diagnosing Cancer: Changes in nuclear stiffness can indicate the presence of malignant cells.
  • Monitoring Treatment Progress: Assessing nuclear elasticity can help evaluate the effectiveness of cancer therapies.
  • Understanding Metastasis: The methodology could potentially elucidate how mechanical properties influence cancer spread to other organs.
"Our work demonstrates that nuclear elasticity is a crucial physical property that reflects the underlying chromatin states," – Takehiko Ichikawa, Research Lead.

Future Directions

The research lays the groundwork for further exploration into the mechanics of other cellular organelles, such as mitochondria, and their roles in cancer progression. Continued investigations involving:

  • Developing therapies targeted at chromatin modifications to alter nuclear mechanics
  • Studying the mechanical forces during cell migration in metastasis
  • Exploring the potential of NE-AFM in other diseases related to cellular mechanics

With ongoing development, NE-AFM is set to enhance clinical diagnostics and treatment strategies, paving the way for more individualized cancer care.

Literature Cited

Ichikawa, T., et al. (2025). Probing Nanomechanics by Direct Indentation Using Nanoendoscopy-AFM Reveals the Nuclear Elasticity Transition in Cancer Cells, ACS Applied Nano Materials. DOI: 10.1021/acsanm.5c03044.